Article
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41.
Antimicrobial agents and chemotherapy - 1 Mar 2005
Xu L, Pozniak A, Wildfire A, Stanfield-Oakley S A, Mosier S M, Ratcliffe D, Workman J, Joall A, Myers R, Smit E, Cane P A, Greenberg M L, Pillay D
Abstract excerpt
The objective of this study was to track the evolution of sequence changes in both the heptad region 1 (HR1) and HR2 domains of gp41 associated with resistance to enfuvirtide (ENF) in a patient cohort receiving long-term ENF treatment. We studied 17 highly antiretroviral agent-experienced patients receiving long-term ENF treatment with virological rebound or a lack of suppression. Sixty-two samples obtained after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
